BioPharm International Sponsored eBooks-09-15-2021

Biopharmaceutical companies are tasked with doing more with less while moving promising biotherapeutics into the clinic as fast as safely possible. Advances in High-Throughput Upstream Process Development takes a deep dive into an approach that addresses this challenge: combining definitive screening designs with advanced machine learning for accelerated drug development. Explore:

• Phase appropriate DOE strategies to minimize development timelines and maximize product life-cycle efficiency
• Efficient sample transfer from bioreactor to analytical platform
• Organizational strategies for data management from research to GMP production